Biotinylated Human FcRH5/FcRL5 Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00344P-100UG

Biotinylated Human FcRH5 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Human FcRH5/FcRL5 Protein (Primary Amine Labeling), Active
Beta LifeScience
SKU/CAT #: BLK-00344P-100UG
Collections: High-quality recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Human FcRH5/FcRL5 Protein (Primary Amine Labeling) is expressed from HEK293 with His tag at the C-Terminus.It contains Gln16-Gly851. |
Purity | > 95% as determined by Tris-Bis PAGE;> 90% as determined by HPLC |
Accession | AAK93971 |
Target Symbol | FcRH5/FcRL5 |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Gln16-Gly851 |
Mol. Weight | The protein has a predicted MW of 92.38 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS, 100mM Arginine (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Anti-FcRH5 Antibody, hFc Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human FcRH5, His Tag with the EC50 of 46.0ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | FcRH5 is a cell surface marker enriched on malignant plasma cells when compared to other hematologic malignancies and normal tissues. DFRF4539A is an anti-FcRH5 antibody-drug conjugated to monomethyl auristatin E (MMAE), a potent anti-mitotic agent. |